Our Science
- Home
- Our Science
Our Science & Philosophy
Transcell Biologics is founded on the belief that the future of medicine requires a deeper understanding of human biology rather than just improved approximations
While the pharmaceutical industry made significant progress in drug, vaccine discovery and development in the late twentieth century, the growing complexity of modern diseases reveals limitations in traditional methods. Many therapies fail in clinical trials because early experimental systems do not effectively replicate human disease biology and patient variability
With chronic and complex diseases becoming more prevalent, Transcell Biologics advocates for a new approach to drug and vaccine discovery
Human Biology First
Our scientific philosophy centers on human biology and the patient, emphasizing direct research from human biological information rather than relying on simplified cell lines or animal models. By using healthy and diseased human cells, tissues, and patient-derived materials, we can more accurately investigate disease mechanisms
Our goal is to understand how diseases emerge, progress, and respond to treatments, particularly in complex fields such as oncology and immunology, where patient-specific responses are crucial for therapeutic success
.
Transcell Biologics sees advanced in vitro and ex vivo human microphysiologies as vital links between experimental science and clinical medicine. These systems allow for the study of human cells and tissues in a way that retains their physiological relevance, enabling better integration of experimental data with computational models for enhanced predictive accuracy
We aim to establish a continually learning framework that combines computational biology and AI with human biological data, enhancing our ability to navigate complex biological systems
Start with human biology. Learn from human biology. Build medicines for humans
Transcell Biologics is dedicated to a future where human-derived biological platforms, advanced cell science, and artificial intelligence collaborate to enhance the predictability, translation, and patient-centered nature of drug and vaccine development
Our scientific approach is based on a straightforward principle:
Start with human biology. Learn from human biology. Develop medicines for humans
This philosophy guides our efforts in DART, Human MicroPhysiological Platforms, patient-derived systems, and AI-driven biological intelligence
Our long-term vision is to establish a human biology intelligence network where decisions are increasingly based on experimentally derived human evidence. This will reduce reliance on models that may not accurately predict human outcomes and facilitate the development of better medicines with greater confidence